These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27060957)

  • 1. Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in Mice.
    Mulder CK; Dong Y; Brugghe HF; Timmermans HA; Tilstra W; Westdijk J; van Riet E; van Steeg H; Hoogerhout P; Eisel UL
    J Alzheimers Dis; 2016; 52(3):1111-23. PubMed ID: 27060957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid β and elicits antibodies against oligomeric and fibrillar amyloid and plaques.
    Hoogerhout P; Kamphuis W; Brugghe HF; Sluijs JA; Timmermans HA; Westdijk J; Zomer G; Boog CJ; Hol EM; van den Dobbelsteen GP
    PLoS One; 2011 Apr; 6(4):e19110. PubMed ID: 21526148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleuropein aglycone counteracts Aβ42 toxicity in the rat brain.
    Luccarini I; Ed Dami T; Grossi C; Rigacci S; Stefani M; Casamenti F
    Neurosci Lett; 2014 Jan; 558():67-72. PubMed ID: 24211687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of estrogen on beta-amyloid-induced cholinergic cell death in the nucleus basalis magnocellularis.
    Szego EM; Csorba A; Janáky T; Kékesi KA; Abrahám IM; Mórotz GM; Penke B; Palkovits M; Murvai U; Kellermayer MS; Kardos J; Juhász GD
    Neuroendocrinology; 2011; 93(2):90-105. PubMed ID: 20938166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
    Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
    J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.
    Sigurdsson EM; Knudsen E; Asuni A; Fitzer-Attas C; Sage D; Quartermain D; Goni F; Frangione B; Wisniewski T
    J Neurosci; 2004 Jul; 24(28):6277-82. PubMed ID: 15254082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice.
    Petrushina I; Ghochikyan A; Mkrtichyan M; Mamikonyan G; Movsesyan N; Ajdari R; Vasilevko V; Karapetyan A; Lees A; Agadjanyan MG; Cribbs DH
    J Neuroinflammation; 2008 Sep; 5():42. PubMed ID: 18823564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease.
    Szigeti C; Bencsik N; Simonka AJ; Legradi A; Kasa P; Gulya K
    Brain Res Bull; 2013 May; 94():9-16. PubMed ID: 23357177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice.
    Sigurdsson EM; Scholtzova H; Mehta PD; Frangione B; Wisniewski T
    Am J Pathol; 2001 Aug; 159(2):439-47. PubMed ID: 11485902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Aβ antibodies induced by Aβ-HBc virus-like particles prevent Aβ aggregation and protect PC12 cells against toxicity of Aβ1-40.
    Feng G; Wang W; Qian Y; Jin H
    J Neurosci Methods; 2013 Aug; 218(1):48-54. PubMed ID: 23701997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
    Kim HD; Jin JJ; Maxwell JA; Fukuchi K
    Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease.
    Zurbriggen R; Amacker M; Kammer AR; Westerfeld N; Borghgraef P; Van Leuven F; Van der Auwera I; Wera S
    J Mol Neurosci; 2005; 27(2):157-66. PubMed ID: 16186626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
    Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
    J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer.
    Lambracht-Washington D; Fu M; Frost P; Rosenberg RN
    Alzheimers Res Ther; 2017 Apr; 9(1):30. PubMed ID: 28441965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
    Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
    J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active immunization of mice with an Abeta-Hsp70 vaccine.
    Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P
    Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation and age-related elevation of amyloid-β within basal forebrain cholinergic neurons in the rhesus monkey.
    Norvin D; Kim G; Baker-Nigh A; Geula C
    Neuroscience; 2015 Jul; 298():102-11. PubMed ID: 25869619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization Against Specific Fragments of Neurotrophin p75 Receptor Protects Forebrain Cholinergic Neurons in the Olfactory Bulbectomized Mice.
    Bobkova N; Vorobyov V; Medvinskaya N; Nesterova I; Tatarnikova O; Nekrasov P; Samokhin A; Deev A; Sengpiel F; Koroev D; Volpina O
    J Alzheimers Dis; 2016 May; 53(1):289-301. PubMed ID: 27163825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease.
    Zhu QB; Unmehopa U; Bossers K; Hu YT; Verwer R; Balesar R; Zhao J; Bao AM; Swaab D
    Brain; 2016 Mar; 139(Pt 3):908-21. PubMed ID: 26792551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.